Oct 17 (Reuters) - Prescient Therapeutics Ltd (PTX) : COMMENCED COLLABORATION WITH US-BASED DRUG DEVELOPMENT CO TO DEVELOP NEW FORMULATIONS OF PH DOMAIN, AKT INHIBITORS